, Tracking Stock Market Picks
Enter Symbol:
Novartis Ag (NVS) [hlAlert]

down 50.17 %

Novartis Ag (NVS) rated Underweight by HSBC Securities

Posted on: Friday,  Feb 29, 2008  8:25 AM ET by HSBC Securities

HSBC Securities rated Underweight Novartis Ag (NYSE: NVS) on 02/29/2008, when the stock price was $49.15. Since
then, Novartis Ag has gained 100.69% as of 01/14/2016's recent price of $98.64.
If you would have followed this HSBC Securities's recommendation on NVS, you would have lost 50.17% of your investment in 2876 days.

Novartis AG, incorporated on February 29, 1996, is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products. The Company?s healthcare solutions portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Its businesses are divided on a worldwide basis into the four operating divisions: Pharmaceuticals, which comprises brand-name patented pharmaceuticals; Vaccines and Diagnostics, which focuses on human vaccines and blood-testing diagnostics; Sandoz, which consists generic pharmaceuticals, and Consumer Health, which includes over-the-counter medicines, animal health medicines, and contact lenses and lens-care products. It operates in approximately 140 countries. In September 2009, Novartis AG announced that its Sandoz division has completed the acquisition of EBEWE Pharma's specialty generic injectables business.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/29/2008 8:25 AM Sell
as of 12/24/2008
1 Week down  -0.90 %
1 Month up  2.64 %
3 Months up  18.27 %
1 YTD up  22.98 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy